ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q1 2025

GOTHENBURG, Sweden, April 3, 2025 /PRNewswire/ — Zinzino group revenue increased with a total of 60 % in Q1 compared with the previous year.

The revenue in March for Zinzino’s sales markets increased by 79% and amounted to SEK 268.0 (149.7) million. Faun Pharma’s external sales decreased and amounted to SEK 7.1 (9.8) million. Overall, the Group increased revenues by 72% to SEK 275.1 (159.5) million compared with the previous year.

The group revenue increased with 60 % for Q1 2025 compared with the first quarter last year and amounted to SEK 725.9 (454.5) million.

Revenues were distributed as follows:

Regions, mSEK	25-mar	24-mar	Change	Q1 2025	Q1 2024	Change
The Nordics	26.4	23.0	15 %	77.0	68.1	13 %
Central Europe	71.1	41.7	71 %	197.9	119.5	66 %
East Europe	34.0	31.9	7 %	97.3	93.8	4 %
South & West Europe	43.8	25.6	71 %	126.1	70.6	79 %
The Baltics	9.7	7.8	24 %	28.9	23.8	21 %
North America	56.1	13.5	316 %	112.2	35.4	217 %
Asia-Pacific	24.8	5.0	396 %	65.3	12.4	427 %
Africa	2.1	1.2	75 %	5.1	3.3	55 %
Zinzino	268.0	149.7	79 %	709.8	426.9	66 %
Faun Pharma	7.1	9.8	-28 %	16.1	27.6	-42 %
Zinzino Group	275.1	159.5	72 %	725.9	454.5	60 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

–Central Europe: Austria, Germany, Switzerland

–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island.

-The Baltics: Estonia, Latvia, Lithuania

–North America: Canada, USA, Mexico

–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

–Africa: South Africa